European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 1.4% for Week

MT Newswires Live00:06

European equities traded in the US as American depositary receipts were tracking higher late Friday morning, rising 0.5% to 1,783.39 on the S&P Europe Select ADR Index, which was up 1.4% for the week.

From continental Europe, the gainers were led by telecommunications company Ericsson (ERIC) and biopharmaceutical company DBV Technologies (DBVT), which climbed 8.9% and 8.6% respectively. They were followed by medical device maker EDAP TMS (EDAP) and telecommunications company Nokia (NOK), which advanced 6.4% and 3.5% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and health tech company Royal Philips (PHG), which fell 2.6% and 1.8% respectively. They were followed by internet browser company Opera (OPRA) and 3D printer company Materialise (MTLS), which lost 1.7% and 1.6% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin (AMRN) and pharmaceutical company Silence Therapeutics (SLN), which rose 4.5% and 3.3% respectively. They were followed by mining company BHP Group (BHP) and oil and gas company BP (BP), which were up 2.9% and 2.6% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Akari Therapeutics (AKTX), which dropped 4.6% and 2.7% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and insurance firm Prudential (PUK), which were down 1.8% and 1% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment